Novel Fluorescent Benzimidazoles: Synthesis, Characterization, Crystal Structure and Evaluation of Their Anticancer Properties
作者:Yeong Yoon、Tze Chia、Ching Quah、Wan Lim、Chuan Oo、Amir Shirazi、Keykavous Parang、Tan Choon
DOI:10.2174/1570178614666161205123900
日期:2017.2.13
Background: The benzimidazole core structure is an interesting platform for drug discovery
since it possess a wide spectrum of pharmacological activities such as antiviral, anti-inflammatory and
anticancer. Previously the antiproliferative effect of novel substituted benzimidazole derivative was
demonstrated based on the ethyl 1-(2-hydroxyethyl)-2-phenyl-1H-benzo[d]imidazole-5-carboxylate
scaffold through the inhibition of sirtuin activity. This work aimed to further explore the previous work
for identifying novel fluorescent benzimidazoles which possess anti proliferative activities based on the
reported scaffold.
Methods: Compounds were synthesized based on a multistep but facile protocol. Structure of the compounds
was elucidated using NMR, FT-IR, LC-MS, elemental analysis and unambiguously confirmed
through crystal X-ray diffraction. Molar extinction coefficient of the autofluorescence compounds were
determined using UV spectroscopy while cancer cell growth inhibitory activity was carried out using
MTS assay.
Results: Four novel benzimidazole derivatives were successfully synthesized in this study. All four
compounds were found to emit blue fluorescence when light-irradiated with molar extinction coefficient
ranging from 21000 to 29000 (mol L-1)-1cm-1. Two of the synthesized compounds showed good anti
proliferative activity against four cancer cell lines tested in this study.
Conclusion: Four novel benzimidazole derivatives presented in this study were synthesized using
multistep protocol starting from 4-fluoro-3-nitrobenzoic acid. Their structures have been elucidated using
multiple techniques such as NMR, FT-IR, LC-MS, elemental analysis and X-ray crystallography
where possible. They were found to have high autofluorescence and two of them were able to inhibit the
growth of cancer cells tested in this study.
背景:苯并咪唑核心结构是一个有趣的药物发现平台,因为它具有广泛的药理活性,如抗病毒、抗炎和抗癌。此前,基于 1-(2-羟乙基)-2-苯基-1H-苯并[d]咪唑-5-羧酸乙酯支架的新型取代苯并咪唑衍生物通过抑制 sirtuin 活性而被证实具有抗增殖作用。这项工作旨在进一步探索以前的工作,在已报道的支架基础上确定具有抗增殖活性的新型荧光苯并咪唑。 方法:化合物的合成基于一个多步骤但简便的方案。利用核磁共振、傅立叶变换红外光谱、液相色谱-质谱、元素分析等方法阐明了化合物的结构,并通过晶体 X 射线衍射得到了明确的证实。利用紫外光谱测定了自发荧光化合物的摩尔消光系数,并利用 MTS 法进行了癌细胞生长抑制活性测定。 结果:本研究成功合成了四种新型苯并咪唑衍生物。所有四种化合物在光照射下都会发出蓝色荧光,摩尔消光系数在 21000 至 29000(mol L-1)-1cm-1 之间。在本研究测试的四种癌细胞株中,有两种合成化合物显示出良好的抗增殖活性。 结论:本研究以 4-氟-3-硝基苯甲酸为起点,采用多步合成法合成了四种新型苯并咪唑衍生物。在可能的情况下,利用核磁共振、傅立叶变换红外光谱、液相色谱-质谱、元素分析和 X 射线晶体学等多种技术阐明了它们的结构。研究发现,它们具有较高的自发荧光,其中两种能够抑制本研究中测试的癌细胞的生长。